{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:51:46Z","timestamp":1790175106274,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.revmed.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T09:00:40Z","timestamp":1538211640000},"page":"918-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["La maladie de Willebrand"],"prefix":"10.1016","volume":"39","author":[{"given":"L.","family":"Calmette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Clauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.08.005_bib0255","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0260","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0265","first-page":"278","article-title":"La maladie de Willebrand","volume":"17","author":"Veyradier","year":"2011","journal-title":"Hematologie"},{"key":"10.1016\/j.revmed.2018.08.005_bib0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","article-title":"Biochemistry and genetics of von Willebrand factor","volume":"67","author":"Sadler","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.revmed.2018.08.005_bib0275","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand's disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.revmed.2018.08.005_bib0280","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/jth.12226","article-title":"Clearance of von Willebrand factor","volume":"11","author":"Casari","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0285","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(95)90166-3","article-title":"Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis","volume":"345","author":"Koster","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2018.08.005_bib0290","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood-2003-05-1505","article-title":"An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13","volume":"103","author":"Bowen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0295","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1538-7836.2007.02444.x","article-title":"Impact of plasma von Willebrand factor levels in the diagnosis of type 1\u00a0von Willebrand disease: results from a multicenter European study (MCMDM-1VWD)","volume":"5","author":"Tosetto","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0300","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3324\/haematol.2012.077263","article-title":"Principles of care for the diagnosis and treatment of von Willebrand disease","volume":"98","author":"Castaman","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2018.08.005_bib0305","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1055\/s-0037-1614855","article-title":"Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive","volume":"82","author":"Kadir","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0310","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/j.1537-2995.2010.02604.x","article-title":"Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents","volume":"50","author":"Klarmann","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.revmed.2018.08.005_bib0315","first-page":"6","article-title":"Facteur Willebrand et maladie de Willebrand\u00a0: pr\u00e9-requis au diagnostic","volume":"20","author":"Fressinaud","year":"2014","journal-title":"Hematologie"},{"key":"10.1016\/j.revmed.2018.08.005_bib0320","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1055\/s-0037-1613140","article-title":"Changes in von Willebrand factor and factor VIII levels during the menstrual cycle","volume":"87","author":"Miller","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0325","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1365-2141.2003.04371.x","article-title":"Reassessment of von Willebrand factor (VWF), VWF propeptide, factor VIII:C and plasminogen activator inhibitors 1\u00a0and 2\u00a0during normal pregnancy","volume":"121","author":"Sie","year":"2003","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.revmed.2018.08.005_bib0330","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9378(90)90594-W","article-title":"Hemostasis profile in women taking low-dose oral contraceptives","volume":"163","author":"David","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.revmed.2018.08.005_bib0335","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2141.1981.tb07197.x","article-title":"Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration","volume":"49","author":"Lombardi","year":"1981","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2018.08.005_bib0340","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1160\/TH12-04-0244","article-title":"Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease","volume":"108","author":"de Wee","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0345","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12571","article-title":"The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease","volume":"21","author":"Makris","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.revmed.2018.08.005_bib0350","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/bjh.12272","article-title":"Von Willebrand disease-associated angiodysplasia: a few answers, still many questions","volume":"161","author":"Franchini","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2018.08.005_bib0355","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2012.09.002","article-title":"Hemophilic arthropathy in patients with von Willebrand disease","volume":"26","author":"van Galen","year":"2012","journal-title":"Blood Rev"},{"key":"10.1016\/j.revmed.2018.08.005_bib0360","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/jth.12799","article-title":"Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels","volume":"13","author":"Bucciarelli","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0365","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/hae.12568","article-title":"Postpartum von Willebrand factor levels in women with and without von Willebrand disease and implications for prophylaxis","volume":"21","author":"James","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.revmed.2018.08.005_bib0370","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1538-7836.2007.02563.x","article-title":"Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0375","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2516.2006.01314.x","article-title":"The obstetric and gynaecological management of women with inherited bleeding disorders \u2013 review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors\u2019 Organization","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"key":"10.1016\/j.revmed.2018.08.005_bib0380","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1\u00a0von Willebrand disease: results from a multicenter European study (MCMDM-1\u00a0VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0385","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.revmed.2018.08.005_bib0390","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V88.7.2433.bloodjournal8872433","article-title":"Dominant type 1\u00a0von Willebrand disease caused by mutated cysteine residues in the D3\u00a0domain of von Willebrand factor","volume":"88","author":"Eikenboom","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0395","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0400","first-page":"30","article-title":"Diagnostic clinique, biologique et mol\u00e9culaire","volume":"20","author":"Fressinaud","year":"2014","journal-title":"Hematologie"},{"key":"10.1016\/j.revmed.2018.08.005_bib0405","first-page":"1","article-title":"Allongement du temps de c\u00e9phaline avec activateur","volume":"12","author":"Calmette","year":"2017","journal-title":"EMC \u2013 AKOS (Trait\u00e9 de M\u00e9decine)"},{"key":"10.1016\/j.revmed.2018.08.005_bib0410","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2018.08.005_bib0415","first-page":"14","article-title":"Techniques biologiques","volume":"20","author":"Caron","year":"2014","journal-title":"Hematologie"},{"key":"10.1016\/j.revmed.2018.08.005_bib0420","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1055\/s-0037-1616109","article-title":"von Willebrand factor subcommittee of the S, Standardization Committee of the International Society on T haemostasis. Recommended abbreviations for von Willebrand factor and its activities","volume":"86","author":"Mazurier","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0425","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1538-7836.2005.01245.x","article-title":"Factor ISSovW. Provisional criteria for the diagnosis of VWD type 1","volume":"3","author":"Sadler","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0430","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1182\/blood-2015-10-673681","article-title":"Clinical and laboratory variability in a cohort of patients diagnosed with type 1\u00a0VWD in the United States","volume":"127","author":"Flood","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0435","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1182\/blood-2002-09-2892","article-title":"Von Willebrand disease type 1: a diagnosis in search of a disease","volume":"101","author":"Sadler","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0440","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.patbio.2005.07.009","article-title":"Type 2B and pseudo type 2B Von Willebrand disease\u00a0; a report of three cases","volume":"54","author":"Guermazi","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.revmed.2018.08.005_bib0445","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2013.02.039","article-title":"Acquired von Willebrand syndrome: a case series of nine patients and literature review","volume":"35","author":"Boissier","year":"2014","journal-title":"Rev Med Interne"},{"issue":"5","key":"10.1016\/j.revmed.2018.08.005_bib0450","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/hae.12984","article-title":"State of the art: von Willebrand disease","volume":"22","author":"James","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.revmed.2018.08.005_bib0455","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0037-1613993","article-title":"Acquired von Willebrand syndrome: from pathophysiology to management","volume":"84","author":"Veyradier","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0460","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra040403","article-title":"Treatment of von Willebrand's disease","volume":"351","author":"Mannucci","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.08.005_bib0465","doi-asserted-by":"crossref","first-page":"E45","DOI":"10.3390\/jcm6040045","article-title":"Diagnosis and treatment of von Willebrand disease and rare bleeding disorders","volume":"6","author":"Castaman","year":"2017","journal-title":"J Clin Med"},{"key":"10.1016\/j.revmed.2018.08.005_bib0470","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1538-7836.2007.02562.x","article-title":"Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin): a prospective study of 50\u00a0patients","volume":"5","author":"Borel-Derlon","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0475","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0037-1613225","article-title":"Venous thromboembolism in von Willebrand disease","volume":"88","author":"Mannucci","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.revmed.2018.08.005_bib0480","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3\u00a0von Willebrand disease: updated results from 40\u00a0multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.revmed.2018.08.005_bib0485","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.08.005_bib0490","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1182\/blood-2017-05-782029","article-title":"Advances in the diagnosis and treatment of Von Willebrand disease","volume":"130","author":"Sharma","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2018.08.005_bib0495","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.revmed.2018.08.005_bib0250","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-02-629873","article-title":"Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand disease","volume":"126","author":"Gill","year":"2015","journal-title":"Blood"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318306738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318306738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:39:38Z","timestamp":1759336778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318306738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0248866318306738"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.08.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La maladie de Willebrand","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}